Delivery Order SPE2DR25D1205-SPE2DR26F0VT3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for Talzenna 0.35 mg softgel capsules (30-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle...
- The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Talzenna 0.5 mg softgels (30-count units) under a firm fixed-price contract with a ceiling value of $11.1K. This delivery order, which has no set-aside designation, represents a competitive award and is due for completion by October 20, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units) with a ceiling value of $11,135.25. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,270.52 to AmerisourceBergen Drug Corp for the supply of Talzenna 0.35 mg softgel capsules (30-count units) under a firm fixed-price contract. The contract, awarded on September 15, 2025, with completion targeted for October 6, 2025, represents a non-competitive delivery order placement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The U.S. Department of Defense's Medical Supply Chain awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 6, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with Defense Logistics Agency Troop Support...
- This federal contract award, valued at $12,246.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Talzenna 0.5 mg softgel capsules, a prescription medication, to support federal medical supply requirements. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of May 6, 2025. There is no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for $11,734.84 to supply TALZENNA 0.35 mg softgel capsules in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award selection. The product will be delivered to the Conshohocken, Pennsylvania location by the ultimate completion date of November 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for the supply of Talzenna 0.25 mg softgel capsules (30-count units) to support federal medical procurement needs. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $22,270.52 with an ultimate completion date of October 15, 2025. The award is funded by the Defense Logistics Agency's Medical...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VT3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,734.84 to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgels (30-count units) under a firm fixed price contract type. The award was issued on October 27, 2025, with an ultimate completion date of November 18, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The competitively awarded delivery order structure demonstrates the company's established capability to meet federal pharmaceutical procurement requirements for defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 10/27/25 |